Disc Medicine, Inc. - 8-K Filing
Disc Medicine presented positive initial results from RESTORE-PV Phase 2 trial showing DISC-3405 reduced phlebotomy and improved symptoms in PV patients. (Items: 7.01 Regulation FD Disclosure, 8.01 Other Events, 9.01 Financial Statements and Exhibits)
Tickers: $IRON